Natixis Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-42,911
| Closed | -$1.87M | – | 1434 |
|
|
2021
Q4 | $1.87M | Buy |
42,911
+7,409
| +21% | +$322K | 0.01% | 967 |
|
|
2021
Q3 | $1.78M | Sell |
35,502
-1,757
| -5% | -$87.9K | 0.01% | 944 |
|
|
2021
Q2 | $2.35M | Sell |
37,259
-18,739
| -33% | -$1.18M | 0.01% | 861 |
|
|
2021
Q1 | $5.2M | Sell |
55,998
-9,631
| -15% | -$895K | 0.03% | 583 |
|
|
2020
Q4 | $5.88M | Buy |
65,629
+26,097
| +66% | +$2.34M | 0.03% | 497 |
|
|
2020
Q3 | $4.09M | Sell |
39,532
-1,589
| -4% | -$164K | 0.03% | 576 |
|
|
2020
Q2 | $3.25M | Sell |
41,121
-11,453
| -22% | -$906K | 0.02% | 650 |
|
|
2020
Q1 | $3.04M | Buy |
52,574
+21,538
| +69% | +$1.25M | 0.02% | 619 |
|
|
2019
Q4 | $1.67M | Sell |
31,036
-18,691
| -38% | -$1.01M | 0.01% | 849 |
|
|
2019
Q3 | $2.6M | Buy |
49,727
+5,577
| +13% | +$291K | 0.02% | 695 |
|
|
2019
Q2 | $2.13M | Buy |
44,150
+5,874
| +15% | +$284K | 0.02% | 757 |
|
|
2019
Q1 | $1.93M | Buy |
+38,276
| New | +$1.93M | 0.02% | 768 |
|